Corbion reports transactions under its current sha
Post# of 301275
Corbion has repurchased 38,500 of its own common shares in the period from July 24, 2017 up to and including July 28, 2017 at an average price of € 27.33 per share. The consideration of the repurchase was € 1.05 million.
Corbion's current share buyback program commenced on 18 April 2017, and details are available on our website at http://www.corbion.com/investor-relations/sha...ck-program
This regular update of the transactions conducted under the share buyback program is to be made public under the EU Market Abuse Regulation.
This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.
Background information: Corbion is the global market leader in lactic acid and lactic acid derivatives, and a leading company in emulsifiers, functional enzyme blends, minerals and vitamins. We develop sustainable solutions to improve the quality of life for people today and generations to come. For over 100 years, we have been uncompromising in our commitment to safety, quality and performance. Drawing on our deep application and product knowledge, we work side-by-side with customers to make our cutting edge technologies work for them. Our solutions help differentiate products in markets such as food, home & personal care, pharmaceuticals, medical devices and bioplastics. In 2016, Corbion generated annual sales of € 911.3 million and had a workforce of 1,684 FTE. Corbion is listed on Euronext Amsterdam. For more information: www.corbion.com
Attachments:
(0)
(0)